Skip to main content

Market Overview

Bristol-Myers, Sanofi Fined $834M In Hawaii Over Plavix: Bloomberg

  • Bristol-Myers Squibb Co (NYSE: BMY) and Sanofi SA (NASDAQ: SNY) were ordered to pay the state of Hawaii more than $834 million for illegally marketing their blood-thinning drug Plavix, Bloomberg reports.
  • Hawaii Attorney General Clare Connors’ lawyers showed the companies didn’t adequately disclose the blood thinner was ineffective for as many as 30% of users in the state, the judge said.
  • “The court’s ruling is unsupported by the law and at odds with the evidence at trial,” the companies said in a joint statement. The companies said they would appeal.
  • Price Action: BMY shares were down 0.5% at $59.68, and SNY decreased 0.53% at $47.33 in market trading hours on the last check Tuesday.

Related Articles (BMY + SNY)

View Comments and Join the Discussion!

Posted-In: Biotech News Health Care FDA Legal Top Stories General

Don't Miss Any Updates!
News Directly in Your Inbox
Subscribe to:
Benzinga Premarket Activity
Get pre-market outlook, mid-day update and after-market roundup emails in your inbox.
Market in 5 Minutes
Everything you need to know about the market - quick & easy.
Fintech Focus
A daily collection of all things fintech, interesting developments and market updates.
Everything you need to know about the latest SPAC news.
Thank You

Thank you for subscribing! If you have any questions feel free to call us at 1-877-440-ZING or email us at